Breast Cancer Therapeutics Market Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Drug Therapy [Targeted Drug Therapy (Abemaciclib, Ado-Trastuzumab Emtansine, Palbociclib, Trastuzumab, and Other Target Drug Therapies), Hormonal Drug Therapy (Selective Estrogen Receptor Modulators, Aromatase Inhibitors, and Selective Estrogen Receptor Downregulators), Chemotherapy, and Immunotherapy/Biological Therapy], Breast Cancer Type (Hormone Receptor, HER2+, and Triple-Negative Breast Cancer), Distribution Channel (Hospital Pharmacies, Drug Stores and Retail Pharmacies, and Online Pharmacies), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Breast Cancer Therapeutics Market Size and Forecast (2020–2030), Global and Regional Share, Trends, and Growth Opportunity Analysis
Coverage: Drug Therapy [Targeted Drug Therapy (Abemaciclib, Ado-Trastuzumab Emtansine, Palbociclib, Trastuzumab, and Other Target Drug Therapies), Hormonal Drug Therapy (Selective Estrogen Receptor Modulators, Aromatase Inhibitors, and Selective Estrogen Receptor Downregulators), Chemotherapy, and Immunotherapy/Biological Therapy], Breast Cancer Type (Hormone Receptor, HER2+, and Triple-Negative Breast Cancer), Distribution Channel (Hospital Pharmacies, Drug Stores and Retail Pharmacies, and Online Pharmacies), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
The breast cancer therapeutics market size is expected to grow from US$ 31,073.52 million in 2022 to US$ 63,967.05 million by 2030; it is estimated to record a CAGR of 9.4% during 2022 to 2030.
Breast cancer is when the breast's cells proliferate out of control. Breast cancer comes in several forms. Which breast cells develop into cancer determines the type of breast cancer. The ducts or lobules are where most breast cancers start. Blood and lymph vessels are two ways breast cancer can travel outside the breast. Its treatment depends on the stage of cancer. It may consist of chemotherapy, radiation, hormone therapy and surgery. The breast cancer therapeutics market growth is attributed to the growing burden of breast cancer and launch of several diagnostics and screening programs.
Personalized medicine involves tailoring treatment plans to individual patients on the basis of their genetic makeup, among other factors. This approach allows for highly targeted and effective treatments, as it considers the unique characteristics of each patient's cancer. Advancements in genomics and molecular diagnostics have made personalized medicine a viable option in breast cancer treatment. Healthcare providers can identify specific genetic mutations or biomarkers driving the cancer's growth by analyzing a patient's tumor at a molecular level. This information can then be used to select the most appropriate treatment options, such as targeted therapies or immunotherapies, that are likely to be the most effective for that particular patient. The use of personalized medicine in breast cancer therapeutics has the potential to significantly improve patient outcomes. For instance, in February 2022, NIH researchers developed a personalized breast cancer therapy approach, an experimental form of immunotherapy that uses a patient’s tumor-fighting immune cells to treat those with metastatic breast cancer, advancing personalized medicine.
By providing tailored treatments to individual patients, healthcare providers can increase the likelihood of successful outcomes and reduce the risk of unnecessary side effects. In addition to improving patient outcomes, personalized medicine also offers economic benefits. By selecting treatments that are more likely to be effective, healthcare providers can reduce healthcare costs associated with ineffective treatments and avoid unnecessary expenses. As advancements in genomics and molecular diagnostics progress, personalized medicine is likely to become increasingly accessible and integrated into standard treatment protocols in the coming years. Therefore, the increasing use of personalized medicine is anticipated to bring new growth trends in the breast cancer therapeutics market.
Distribution Channel -Based Insights
Based on distribution channel, the breast cancer therapeutics market is segmented into hospital pharmacies, drug stores and retail pharmacies, and online pharmacies. The hospital pharmacies segment held the largest market share in 2022. The hospital pharmacy plays a crucial role in the management of breast cancer therapeutics. They are responsible for compounding and dispensing, monitoring drug safety, medication management, educating patients, and other factors. Breast cancer is one of the most widespread cancers worldwide, and the demand for effective therapeutics is steadily increasing. Hospital pharmacies are responsible for procuring, storing, and dispensing chemotherapy medications and other treatments related to breast cancer to ensure that patients receive the right treatment in time. These pharmacies are also in authority to manage the inventory and storage of these drugs, ensuring that they are stored and handled in accordance with strict regulations. Their collaborative efforts with oncologists and healthcare teams ensure that breast cancer patients receive optimal, personalized therapeutics and comprehensive care throughout their treatment journey. Hospital pharmacies remain instrumental in delivering timely and effective breast cancer treatments, significantly impacting patients’ outcomes in battling the disease.
However, the online pharmacies segment is anticipated to register the highest CAGR during 2022–2030. Online pharmacies offer a wide array of breast cancer medications ranging from chemotherapy drugs to supportive therapies, often with home delivery services. Ensuring prescription verification and maintaining regulatory compliance, online pharmacies play a vital role in upholding the integrity of the healthcare system. They also provide convenience for patients who prefer discrete shopping or have limited mobility due to treatment. They also enable patients to compare prices and access a broader selection of breast cancer therapeutics. With services such as home delivery and patient support, online pharmacies continue to evolve, transforming the breast cancer treatment experience and breaking down geographical barriers for patients worldwide. In addition, an increasing number of patients have shifted to these pharmacies to acquire therapeutics due to their greater ease in terms of usage, which is fueling the growth of the segment.
Europe is the second leading region in the market. Breast cancer is a common type of cancer in the UK. As per the National Health Service (NHS), about one in seven women are diagnosed with breast cancer during their lifespan in Great Britain data. Each year, ~55,000 women are diagnosed with breast cancer.
Greater demand from the medical industry to treat breast cancer patients with novel therapeutics has led to greater investment in R&D, fueling the growth of the market. Companies invest in research and development to stay competitive and provide customers with cutting-edge and innovative products. In October 2021, Trodelvy, a new antibody treatment, was authorized to treat an aggressive form of cancer called ‘triple-negative breast cancer’ in the country. In November 2021, Sanofi invested US$ 180 million and entered into a new strategic collaboration with Owkin, a French-American AI start-up engaged in the discovery and development programs of four types of cancer, with a total payment of US$ 90 million. The collaboration supported Sanofi’s developing oncology portfolio in core areas such as breast cancer, lung cancer, and multiple myeloma to enhance clinical trial design and detect predictive biomarkers for diseases and treatment results.
The Italian government and national health institutes have launched several initiatives for the early detection and treatment of breast cancer. These programs include free mammograms for women aged 50–69 and a nationwide breast cancer screening program. In addition, as per the information provided by EURACTIV, the country has witnessed a strong rise in the number of specialized Breast Units, from 84 in 2012 to 173 in 2020. The country's growing number of breast units helps healthcare professionals offer treatment to patients with breast cancer. Thus, the abovementioned factors support the market growth in the region.
The American Cancer S0ociety, World Health Organization (WHO), National Institutes of Health, and US FDA are among the primary and secondary sources referred to while preparing the breast cancer therapeutics market report.
Coverage: Drug Therapy [Targeted Drug Therapy (Abemaciclib, Ado-Trastuzumab Emtansine, Palbociclib, Trastuzumab, and Other Target Drug Therapies), Hormonal Drug Therapy (Selective Estrogen Receptor Modulators, Aromatase Inhibitors, and Selective Estrogen Receptor Downregulators), Chemotherapy, and Immunotherapy/Biological Therapy], Breast Cancer Type (Hormone Receptor, HER2+, and Triple-Negative Breast Cancer), Distribution Channel (Hospital Pharmacies, Drug Stores and Retail Pharmacies, and Online Pharmacies), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
The breast cancer therapeutics market size is expected to grow from US$ 31,073.52 million in 2022 to US$ 63,967.05 million by 2030; it is estimated to record a CAGR of 9.4% during 2022 to 2030.
Breast cancer is when the breast's cells proliferate out of control. Breast cancer comes in several forms. Which breast cells develop into cancer determines the type of breast cancer. The ducts or lobules are where most breast cancers start. Blood and lymph vessels are two ways breast cancer can travel outside the breast. Its treatment depends on the stage of cancer. It may consist of chemotherapy, radiation, hormone therapy and surgery. The breast cancer therapeutics market growth is attributed to the growing burden of breast cancer and launch of several diagnostics and screening programs.
Personalized medicine involves tailoring treatment plans to individual patients on the basis of their genetic makeup, among other factors. This approach allows for highly targeted and effective treatments, as it considers the unique characteristics of each patient's cancer. Advancements in genomics and molecular diagnostics have made personalized medicine a viable option in breast cancer treatment. Healthcare providers can identify specific genetic mutations or biomarkers driving the cancer's growth by analyzing a patient's tumor at a molecular level. This information can then be used to select the most appropriate treatment options, such as targeted therapies or immunotherapies, that are likely to be the most effective for that particular patient. The use of personalized medicine in breast cancer therapeutics has the potential to significantly improve patient outcomes. For instance, in February 2022, NIH researchers developed a personalized breast cancer therapy approach, an experimental form of immunotherapy that uses a patient’s tumor-fighting immune cells to treat those with metastatic breast cancer, advancing personalized medicine.
By providing tailored treatments to individual patients, healthcare providers can increase the likelihood of successful outcomes and reduce the risk of unnecessary side effects. In addition to improving patient outcomes, personalized medicine also offers economic benefits. By selecting treatments that are more likely to be effective, healthcare providers can reduce healthcare costs associated with ineffective treatments and avoid unnecessary expenses. As advancements in genomics and molecular diagnostics progress, personalized medicine is likely to become increasingly accessible and integrated into standard treatment protocols in the coming years. Therefore, the increasing use of personalized medicine is anticipated to bring new growth trends in the breast cancer therapeutics market.
Distribution Channel -Based Insights
Based on distribution channel, the breast cancer therapeutics market is segmented into hospital pharmacies, drug stores and retail pharmacies, and online pharmacies. The hospital pharmacies segment held the largest market share in 2022. The hospital pharmacy plays a crucial role in the management of breast cancer therapeutics. They are responsible for compounding and dispensing, monitoring drug safety, medication management, educating patients, and other factors. Breast cancer is one of the most widespread cancers worldwide, and the demand for effective therapeutics is steadily increasing. Hospital pharmacies are responsible for procuring, storing, and dispensing chemotherapy medications and other treatments related to breast cancer to ensure that patients receive the right treatment in time. These pharmacies are also in authority to manage the inventory and storage of these drugs, ensuring that they are stored and handled in accordance with strict regulations. Their collaborative efforts with oncologists and healthcare teams ensure that breast cancer patients receive optimal, personalized therapeutics and comprehensive care throughout their treatment journey. Hospital pharmacies remain instrumental in delivering timely and effective breast cancer treatments, significantly impacting patients’ outcomes in battling the disease.
However, the online pharmacies segment is anticipated to register the highest CAGR during 2022–2030. Online pharmacies offer a wide array of breast cancer medications ranging from chemotherapy drugs to supportive therapies, often with home delivery services. Ensuring prescription verification and maintaining regulatory compliance, online pharmacies play a vital role in upholding the integrity of the healthcare system. They also provide convenience for patients who prefer discrete shopping or have limited mobility due to treatment. They also enable patients to compare prices and access a broader selection of breast cancer therapeutics. With services such as home delivery and patient support, online pharmacies continue to evolve, transforming the breast cancer treatment experience and breaking down geographical barriers for patients worldwide. In addition, an increasing number of patients have shifted to these pharmacies to acquire therapeutics due to their greater ease in terms of usage, which is fueling the growth of the segment.
Europe is the second leading region in the market. Breast cancer is a common type of cancer in the UK. As per the National Health Service (NHS), about one in seven women are diagnosed with breast cancer during their lifespan in Great Britain data. Each year, ~55,000 women are diagnosed with breast cancer.
Greater demand from the medical industry to treat breast cancer patients with novel therapeutics has led to greater investment in R&D, fueling the growth of the market. Companies invest in research and development to stay competitive and provide customers with cutting-edge and innovative products. In October 2021, Trodelvy, a new antibody treatment, was authorized to treat an aggressive form of cancer called ‘triple-negative breast cancer’ in the country. In November 2021, Sanofi invested US$ 180 million and entered into a new strategic collaboration with Owkin, a French-American AI start-up engaged in the discovery and development programs of four types of cancer, with a total payment of US$ 90 million. The collaboration supported Sanofi’s developing oncology portfolio in core areas such as breast cancer, lung cancer, and multiple myeloma to enhance clinical trial design and detect predictive biomarkers for diseases and treatment results.
The Italian government and national health institutes have launched several initiatives for the early detection and treatment of breast cancer. These programs include free mammograms for women aged 50–69 and a nationwide breast cancer screening program. In addition, as per the information provided by EURACTIV, the country has witnessed a strong rise in the number of specialized Breast Units, from 84 in 2012 to 173 in 2020. The country's growing number of breast units helps healthcare professionals offer treatment to patients with breast cancer. Thus, the abovementioned factors support the market growth in the region.
The American Cancer S0ociety, World Health Organization (WHO), National Institutes of Health, and US FDA are among the primary and secondary sources referred to while preparing the breast cancer therapeutics market report.
1. INTRODUCTION
1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation
2. EXECUTIVE SUMMARY
2.1 Key Insights
3. RESEARCH METHODOLOGY
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. BREAST CANCER THERAPEUTICS MARKET LANDSCAPE
4.1 Overview
4.2 PEST Analysis
4.2.1 Global PEST Analysis
5. BREAST CANCER THERAPEUTICS MARKET - KEY INDUSTRY DYNAMICS
5.1 Key Market Drivers
5.1.1 Growing Burden of Breast Cancer
5.1.2 Launch of Several Diagnostics and Screening Programs
5.2 Key Market Restraints
5.2.1 High Cost of Diagnosis and Treatment
5.3 Key Market Opportunities
5.3.1 Increased Support from Government and Private Organizations
5.4 Key Future Trends
5.4.1 Increasing Use of Personalized Medicine
5.5 Impact Analysis:
6. BREAST CANCER THERAPEUTICS MARKET - GLOBAL MARKET ANALYSIS
6.1 Breast Cancer Therapeutics Market Revenue (US$ Mn), 2022 2030
7. GLOBAL BREAST CANCER THERAPEUTICS MARKET REVENUE AND FORECAST TO 2030 BY DRUG THERAPY
7.1 Overview
7.2 Breast Cancer Therapeutics Market Revenue Share, by Drug Therapy, 2022 & 2030 (%)
7.3 Targeted Drug Therapy
7.3.1 Overview
7.3.2 Targeted Drug Therapy: Breast Cancer Therapeutics Market Revenue and Forecast to 2030 (US$ Million)
7.3.2.1 Global Breast Cancer Therapeutics Market, by Targeted Drug Therapy, 2020 Ђ“2030 (US$ Million)
7.4 Hormonal Drug Therapy
7.4.1 Overview
7.4.2 Hormonal Drug Therapy: Breast Cancer Therapeutics Market Revenue and Forecast to 2030 (US$ Million)
7.5 Chemotherapy
7.5.1 Overview
7.5.2 Chemotherapy: Breast Cancer Therapeutics Market Revenue and Forecast to 2030 (US$ Million)
7.6 Immunotherapy/ Biological Therapy
7.6.1 Overview
7.6.2 Immunotherapy/ Biological Therapy: Breast Cancer Therapeutics Market Revenue and Forecast to 2030 (US$ Million)
8. GLOBAL BREAST CANCER THERAPEUTICS MARKET REVENUE AND FORECAST TO 2030 BY BREAST CANCER TYPE
8.1 Overview
8.2 Breast Cancer Therapeutics Market Revenue Share, by Breast Cancer Type, 2022 & 2030 (%)
8.3 Hormone Receptor
8.3.1 Overview
8.3.2 Hormone Receptor: Breast Cancer Therapeutics Market Revenue and Forecast to 2030 (US$ Million)
8.4 HER2+ (human epidermal growth factor receptor 2)
8.4.1 Overview
8.4.2 HER2+: Breast Cancer Therapeutics Market Revenue and Forecast to 2030 (US$ Million)
8.5 Triple-Negative Breast Cancer
8.5.1 Overview
8.5.2 Triple-Negative Breast Cancer: Breast Cancer Therapeutics Market Revenue and Forecast to 2030 (US$ Million)
9. GLOBAL BREAST CANCER THERAPEUTICS MARKET REVENUE AND FORECAST TO 2030 BY DISTRIBUTION CHANNEL
9.1 Overview
9.2 Breast Cancer Therapeutics Market Revenue Share, by Distribution Channel, 2022 & 2030 (%)
9.3 Hospital Pharmacies
9.3.1 Overview
9.3.2 Hospital Pharmacies: Breast Cancer Therapeutics Market Revenue and Forecast to 2030 (US$ Million)
9.4 Drug Store and Retail Pharmacies
9.4.1 Overview
9.4.2 Drug Store and Retail Pharmacies: Breast Cancer Therapeutics Market Revenue and Forecast to 2030 (US$ Million)
9.5 Online Pharmacies
9.5.1 Overview
9.5.2 Online Pharmacies: Breast Cancer Therapeutics Market Revenue and Forecast to 2030 (US$ Million)
10. BREAST CANCER THERAPEUTICS MARKET - GEOGRAPHICAL ANALYSIS
10.1 North America Breast Cancer Therapeutics Market, Revenue and Forecast To 2030
10.1.1 Overview
10.1.2 North America Breast Cancer Therapeutics Market Revenue and Forecast to 2030 (US$ Mn)
10.1.3 North America: Breast Cancer Therapeutics Market, by Drug Therapy, 2020 Ђ“2030 (US$ Million)
10.1.3.1 North America: Breast Cancer Therapeutics Market, For Targeted Drug Therapy by Drug Therapy, 2020 Ђ“2030 (US$ Million)
10.1.3.2 North America: Breast Cancer Therapeutics Market, For Hormonal Drug Therapy by Drug Therapy, 2020 Ђ“2030 (US$ Million)
10.1.4 North America: Breast Cancer Therapeutics Market, by Breast Cancer Type, 2020 Ђ“2030 (US$ Million)
10.1.5 North America: Breast Cancer Therapeutics Market, by Distribution Channel, 2020 Ђ“2030 (US$ Million)
10.1.6 North America Breast Cancer Therapeutics Market, by Country
10.1.6.1 US
10.1.6.1.1 US Breast Cancer Therapeutics Market Revenue and Forecast to 2030 (US$ Mn)
10.1.6.1.2 US: Breast Cancer Therapeutics Market, by Drug Therapy, 2020 Ђ“2030 (US$ Million)
10.1.6.1.2.1 US: Breast Cancer Therapeutics Market, For Targeted Drug Therapy by Drug Therapy, 2020 Ђ“2030 (US$ Million)
10.1.6.1.2.2 US: Breast Cancer Therapeutics Market, For Hormonal Drug Therapy by Drug Therapy, 2020 Ђ“2030 (US$ Million)
10.1.6.1.3 US: Breast Cancer Therapeutics Market, by Breast Cancer Type, 2020 Ђ“2030 (US$ Million)
10.1.6.1.4 US: Breast Cancer Therapeutics Market, by Distribution Channel, 2020 Ђ“2030 (US$ Million)
10.1.6.2 Canada
10.1.6.2.1 Canada Breast Cancer Therapeutics Market Revenue and Forecast to 2030 (US$ Mn)
10.1.6.2.2 Canada: Breast Cancer Therapeutics Market, by Drug Therapy, 2020 Ђ“2030 (US$ Million)
10.1.6.2.2.1 Canada: Breast Cancer Therapeutics Market, For Targeted Drug Therapy by Drug Therapy, 2020 Ђ“2030 (US$ Million)
10.1.6.2.2.2 Canada: Breast Cancer Therapeutics Market, For Hormonal Drug Therapy by Drug Therapy, 2020 Ђ“2030 (US$ Million)
10.1.6.2.3 Canada: Breast Cancer Therapeutics Market, by Breast Cancer Type, 2020 Ђ“2030 (US$ Million)
10.1.6.2.4 Canada: Breast Cancer Therapeutics Market, by Distribution Channel, 2020 Ђ“2030 (US$ Million)
10.1.6.3 Mexico
10.1.6.3.1 Mexico Breast Cancer Therapeutics Market Revenue and Forecast to 2030 (US$ Mn)
10.1.6.3.2 Mexico: Breast Cancer Therapeutics Market, by Drug Therapy, 2020 Ђ“2030 (US$ Million)
10.1.6.3.2.1 Mexico: Breast Cancer Therapeutics Market, For Targeted Drug Therapy by Drug Therapy, 2020 Ђ“2030 (US$ Million)
10.1.6.3.2.2 Mexico: Breast Cancer Therapeutics Market, For Hormonal Drug Therapy by Drug Therapy, 2020 Ђ“2030 (US$ Million)
10.1.6.3.3 Mexico: Breast Cancer Therapeutics Market, by Breast Cancer Type, 2020 Ђ“2030 (US$ Million)
10.1.6.3.4 Mexico: Breast Cancer Therapeutics Market, by Distribution Channel, 2020 Ђ“2030 (US$ Million)
10.2 Europe Breast Cancer Therapeutics Market, Revenue and Forecast to 2030
10.2.1 Overview
10.2.2 Europe Breast Cancer Therapeutics Market Revenue and Forecast to 2030 (US$ Mn)
10.2.3 Europe: Breast Cancer Therapeutics Market, by Drug Therapy, 2020 Ђ“2030 (US$ Million)
10.2.3.1 Europe: Breast Cancer Therapeutics Market, For Targeted Drug Therapy by Drug Therapy, 2020 Ђ“2030 (US$ Million)
10.2.3.2 Europe: Breast Cancer Therapeutics Market, For Hormonal Drug Therapy by Drug Therapy, 2020 Ђ“2030 (US$ Million)
10.2.4 Europe: Breast Cancer Therapeutics Market, by Breast Cancer Type, 2020 Ђ“2030 (US$ Million)
10.2.5 Europe: Breast Cancer Therapeutics Market, by Distribution Channel, 2020 Ђ“2030 (US$ Million)
10.2.6 Europe Breast Cancer Therapeutics Market, by Country
10.2.6.1 UK
10.2.6.1.1 UK Breast Cancer Therapeutics Market Revenue and Forecast to 2030 (US$ Mn)
10.2.6.1.2 UK: Breast Cancer Therapeutics Market, by Drug Therapy, 2020 Ђ“2030 (US$ Million)
10.2.6.1.2.1 UK: Breast Cancer Therapeutics Market, For Targeted Drug Therapy by Drug Therapy, 2020 Ђ“2030 (US$ Million)
10.2.6.1.2.2 UK: Breast Cancer Therapeutics Market, For Hormonal Drug Therapy by Drug Therapy, 2020 Ђ“2030 (US$ Million)
10.2.6.1.3 UK: Breast Cancer Therapeutics Market, by Breast Cancer Type, 2020 Ђ“2030 (US$ Million)
10.2.6.1.4 UK: Breast Cancer Therapeutics Market, by Distribution Channel, 2020 Ђ“2030 (US$ Million)
10.2.6.2 Germany
10.2.6.2.1 Germany Breast Cancer Therapeutics Market Revenue and Forecast to 2030 (US$ Mn)
10.2.6.2.2 Germany: Breast Cancer Therapeutics Market, by Drug Therapy, 2020 Ђ“2030 (US$ Million)
10.2.6.2.2.1 Germany: Breast Cancer Therapeutics Market, For Targeted Drug Therapy by Drug Therapy, 2020 Ђ“2030 (US$ Million)
10.2.6.2.2.2 Germany: Breast Cancer Therapeutics Market, For Hormonal Drug Therapy by Drug Therapy, 2020 Ђ“2030 (US$ Million)
10.2.6.2.3 Germany: Breast Cancer Therapeutics Market, by Breast Cancer Type, 2020 Ђ“2030 (US$ Million)
10.2.6.2.4 Germany: Breast Cancer Therapeutics Market, by Distribution Channel, 2020 Ђ“2030 (US$ Million)
10.2.6.3 France
10.2.6.3.1 France Breast Cancer Therapeutics Market Revenue and Forecast to 2030 (US$ Mn)
10.2.6.3.2 France: Breast Cancer Therapeutics Market, by Drug Therapy, 2020 Ђ“2030 (US$ Million)
10.2.6.3.2.1 France: Breast Cancer Therapeutics Market, For Targeted Drug Therapy by Drug Therapy, 2020 Ђ“2030 (US$ Million)
10.2.6.3.2.2 France: Breast Cancer Therapeutics Market, For Hormonal Drug Therapy by Drug Therapy, 2020 Ђ“2030 (US$ Million)
10.2.6.3.3 France: Breast Cancer Therapeutics Market, by Breast Cancer Type, 2020 Ђ“2030 (US$ Million)
10.2.6.3.4 France: Breast Cancer Therapeutics Market, by Distribution Channel, 2020 Ђ“2030 (US$ Million)
10.2.6.4 Italy
10.2.6.4.1 Italy Breast Cancer Therapeutics Market Revenue and Forecast to 2030 (US$ Mn)
10.2.6.4.2 Italy: Breast Cancer Therapeutics Market, by Drug Therapy, 2020 Ђ“2030 (US$ Million)
10.2.6.4.2.1 Italy: Breast Cancer Therapeutics Market, For Targeted Drug Therapy by Drug Therapy, 2020 Ђ“2030 (US$ Million)
10.2.6.4.2.2 Italy: Breast Cancer Therapeutics Market, For Hormonal Drug Therapy by Drug Therapy, 2020 Ђ“2030 (US$ Million)
10.2.6.4.3 Italy: Breast Cancer Therapeutics Market, by Breast Cancer Type, 2020 Ђ“2030 (US$ Million)
10.2.6.4.4 Italy: Breast Cancer Therapeutics Market, by Distribution Channel, 2020 Ђ“2030 (US$ Million)
10.2.6.5 Spain
10.2.6.5.1 Spain Breast Cancer Therapeutics Market Revenue and Forecast to 2030 (US$ Mn)
10.2.6.5.2 Spain: Breast Cancer Therapeutics Market, by Drug Therapy, 2020 Ђ“2030 (US$ Million)
10.2.6.5.2.1 Spain: Breast Cancer Therapeutics Market, For Targeted Drug Therapy by Drug Therapy, 2020 Ђ“2030 (US$ Million)
10.2.6.5.2.2 Spain: Breast Cancer Therapeutics Market, For Hormonal Drug Therapy by Drug Therapy, 2020 Ђ“2030 (US$ Million)
10.2.6.5.3 Spain: Breast Cancer Therapeutics Market, by Breast Cancer Type, 2020 Ђ“2030 (US$ Million)
10.2.6.5.4 Spain: Breast Cancer Therapeutics Market, by Distribution Channel, 2020 Ђ“2030 (US$ Million)
10.2.6.6 Rest of Europe
10.2.6.6.1 Rest of Europe Breast Cancer Therapeutics Market Revenue and Forecast to 2030 (US$ Mn)
10.2.6.6.2 Rest of Europe: Breast Cancer Therapeutics Market, by Drug Therapy, 2020 Ђ“2030 (US$ Million)
10.2.6.6.2.1 Rest of Europe: Breast Cancer Therapeutics Market, For Targeted Drug Therapy by Drug Therapy, 2020 Ђ“2030 (US$ Million)
10.2.6.6.2.2 Rest of Europe: Breast Cancer Therapeutics Market, For Hormonal Drug Therapy by Drug Therapy, 2020 Ђ“2030 (US$ Million)
10.2.6.6.3 Rest of Europe: Breast Cancer Therapeutics Market, by Breast Cancer Type, 2020 Ђ“2030 (US$ Million)
10.2.6.6.4 Rest of Europe: Breast Cancer Therapeutics Market, by Distribution Channel, 2020 Ђ“2030 (US$ Million)
10.3 Asia Pacific Breast Cancer Therapeutics Market, Revenue and Forecast to 2030
10.3.1 Overview
10.3.2 Asia Pacific Breast Cancer Therapeutics Market Revenue and Forecast to 2030 (US$ Mn)
10.3.3 Asia Pacific: Breast Cancer Therapeutics Market, by Drug Therapy, 2020 Ђ“2030 (US$ Million)
10.3.3.1 Asia Pacific: Breast Cancer Therapeutics Market, For Targeted Drug Therapy by Drug Therapy, 2020 Ђ“2030 (US$ Million)
10.3.3.2 Asia Pacific: Breast Cancer Therapeutics Market, For Hormonal Drug Therapy by Drug Therapy, 2020 Ђ“2030 (US$ Million)
10.3.4 Asia Pacific: Breast Cancer Therapeutics Market, by Breast Cancer Type, 2020 Ђ“2030 (US$ Million)
10.3.5 Asia Pacific: Breast Cancer Therapeutics Market, by Distribution Channel, 2020 Ђ“2030 (US$ Million)
10.3.6 Asia Pacific Breast Cancer Therapeutics Market, by Country
10.3.6.1 China
10.3.6.1.1 China Breast Cancer Therapeutics Market Revenue and Forecast to 2030 (US$ Mn)
10.3.6.1.2 China: Breast Cancer Therapeutics Market, by Drug Therapy, 2020 Ђ“2030 (US$ Million)
10.3.6.1.2.1 China: Breast Cancer Therapeutics Market, For Targeted Drug Therapy by Drug Therapy, 2020 Ђ“2030 (US$ Million)
10.3.6.1.2.2 China: Breast Cancer Therapeutics Market, For Hormonal Drug Therapy by Drug Therapy, 2020 Ђ“2030 (US$ Million)
10.3.6.1.3 China: Breast Cancer Therapeutics Market, by Breast Cancer Type, 2020 Ђ“2030 (US$ Million)
10.3.6.1.4 China: Breast Cancer Therapeutics Market, by Distribution Channel, 2020 Ђ“2030 (US$ Million)
10.3.6.2 Japan
10.3.6.2.1 Japan Breast Cancer Therapeutics Market Revenue and Forecast to 2030 (US$ Mn)
10.3.6.2.2 Japan: Breast Cancer Therapeutics Market, by Drug Therapy, 2020 Ђ“2030 (US$ Million)
10.3.6.2.2.1 Japan: Breast Cancer Therapeutics Market, For Targeted Drug Therapy by Drug Therapy, 2020 Ђ“2030 (US$ Million)
10.3.6.2.2.2 Japan: Breast Cancer Therapeutics Market, For Hormonal Drug Therapy by Drug Therapy, 2020 Ђ“2030 (US$ Million)
10.3.6.2.3 Japan: Breast Cancer Therapeutics Market, by Breast Cancer Type, 2020 Ђ“2030 (US$ Million)
10.3.6.2.4 Japan: Breast Cancer Therapeutics Market, by Distribution Channel, 2020 Ђ“2030 (US$ Million)
10.3.6.3 India
10.3.6.3.1 India Breast Cancer Therapeutics Market Revenue and Forecast to 2030 (US$ Mn)
10.3.6.3.2 India: Breast Cancer Therapeutics Market, by Drug Therapy, 2020 Ђ“2030 (US$ Million)
10.3.6.3.2.1 India: Breast Cancer Therapeutics Market, For Targeted Drug Therapy by Drug Therapy, 2020 Ђ“2030 (US$ Million)
10.3.6.3.2.2 India: Breast Cancer Therapeutics Market, For Hormonal Drug Therapy by Drug Therapy, 2020 Ђ“2030 (US$ Million)
10.3.6.3.3 India: Breast Cancer Therapeutics Market, by Breast Cancer Type, 2020 Ђ“2030 (US$ Million)
10.3.6.3.4 India: Breast Cancer Therapeutics Market, by Distribution Channel, 2020 Ђ“2030 (US$ Million)
10.3.6.4 Australia
10.3.6.4.1 Australia Breast Cancer Therapeutics Market Revenue and Forecast to 2030 (US$ Mn)
10.3.6.4.2 Australia: Breast Cancer Therapeutics Market, by Drug Therapy, 2020 Ђ“2030 (US$ Million)
10.3.6.4.2.1 Australia: Breast Cancer Therapeutics Market, For Targeted Drug Therapy by Drug Therapy, 2020 Ђ“2030 (US$ Million)
10.3.6.4.2.2 Australia: Breast Cancer Therapeutics Market, For Hormonal Drug Therapy by Drug Therapy, 2020 Ђ“2030 (US$ Million)
10.3.6.4.3 Australia: Breast Cancer Therapeutics Market, by Breast Cancer Type, 2020 Ђ“2030 (US$ Million)
10.3.6.4.4 Australia: Breast Cancer Therapeutics Market, by Distribution Channel, 2020 Ђ“2030 (US$ Million)
10.3.6.5 South Korea
10.3.6.5.1 South Korea Breast Cancer Therapeutics Market Revenue and Forecast to 2030 (US$ Mn)
10.3.6.5.2 South Korea: Breast Cancer Therapeutics Market, by Drug Therapy, 2020 Ђ“2030 (US$ Million)
10.3.6.5.2.1 South Korea: Breast Cancer Therapeutics Market, For Targeted Drug Therapy by Drug Therapy, 2020 Ђ“2030 (US$ Million)
10.3.6.5.2.2 South Korea: Breast Cancer Therapeutics Market, For Hormonal Drug Therapy by Drug Therapy, 2020 Ђ“2030 (US$ Million)
10.3.6.5.3 South Korea: Breast Cancer Therapeutics Market, by Breast Cancer Type, 2020 Ђ“2030 (US$ Million)
10.3.6.5.4 South Korea: Breast Cancer Therapeutics Market, by Distribution Channel, 2020 Ђ“2030 (US$ Million)
10.3.6.6 Rest of Asia Pacific
10.3.6.6.1 Rest of Asia Pacific Breast Cancer Therapeutics Market Revenue and Forecast to 2030 (US$ Mn)
10.3.6.6.2 Rest of Asia Pacific: Breast Cancer Therapeutics Market, by Drug Therapy, 2020 Ђ“2030 (US$ Million)
10.3.6.6.2.1 Rest of Asia Pacific: Breast Cancer Therapeutics Market, For Targeted Drug Therapy by Drug Therapy, 2020 Ђ“2030 (US$ Million)
10.3.6.6.2.2 Rest of Asia Pacific: Breast Cancer Therapeutics Market, For Hormonal Drug Therapy by Drug Therapy, 2020 Ђ“2030 (US$ Million)
10.3.6.6.3 Rest of Asia Pacific: Breast Cancer Therapeutics Market, by Breast Cancer Type, 2020 Ђ“2030 (US$ Million)
10.3.6.6.4 Rest of Asia Pacific: Breast Cancer Therapeutics Market, by Distribution Channel, 2020 Ђ“2030 (US$ Million)
10.4 Middle East & Africa Breast Cancer Therapeutics Market, Revenue and Forecast to 2030
10.4.1 Overview
10.4.2 Middle East & Africa Breast Cancer Therapeutics Market Revenue and Forecast to 2030 (US$ Mn)
10.4.3 Middle East & Africa: Breast Cancer Therapeutics Market, by Drug Therapy, 2020 Ђ“2030 (US$ Million)
10.4.3.1 Middle East & Africa: Breast Cancer Therapeutics Market, For Targeted Drug Therapy by Drug Therapy, 2020 Ђ“2030 (US$ Million)
10.4.3.2 Middle East & Africa: Breast Cancer Therapeutics Market, For Hormonal Drug Therapy by Drug Therapy, 2020 Ђ“2030 (US$ Million)
10.4.4 Middle East & Africa: Breast Cancer Therapeutics Market, by Breast Cancer Type, 2020 Ђ“2030 (US$ Million)
10.4.5 Middle East & Africa: Breast Cancer Therapeutics Market, by Distribution Channel, 2020 Ђ“2030 (US$ Million)
10.4.6 Middle East & Africa Breast Cancer Therapeutics Market, by Country
10.4.6.1 Saudi Arabia
10.4.6.1.1 Saudi Arabia Breast Cancer Therapeutics Market Revenue and Forecast to 2030 (US$ Mn)
10.4.6.1.2 Saudi Arabia: Breast Cancer Therapeutics Market, by Drug Therapy, 2020 Ђ“2030 (US$ Million)
10.4.6.1.2.1 Saudi Arabia: Breast Cancer Therapeutics Market, For Targeted Drug Therapy by Drug Therapy, 2020 Ђ“2030 (US$ Million)
10.4.6.1.2.2 Saudi Arabia: Breast Cancer Therapeutics Market, For Hormonal Drug Therapy by Drug Therapy, 2020 Ђ“2030 (US$ Million)
10.4.6.1.3 Saudi Arabia: Breast Cancer Therapeutics Market, by Breast Cancer Type, 2020 Ђ“2030 (US$ Million)
10.4.6.1.4 Saudi Arabia: Breast Cancer Therapeutics Market, by Distribution Channel, 2020 Ђ“2030 (US$ Million)
10.4.6.2 UAE
10.4.6.2.1 UAE Breast Cancer Therapeutics Market Revenue and Forecast to 2030 (US$ Mn)
10.4.6.2.2 UAE: Breast Cancer Therapeutics Market, by Drug Therapy, 2020 Ђ“2030 (US$ Million)
10.4.6.2.2.1 UAE: Breast Cancer Therapeutics Market, For Targeted Drug Therapy by Drug Therapy, 2020 Ђ“2030 (US$ Million)
10.4.6.2.2.2 UAE: Breast Cancer Therapeutics Market, For Hormonal Drug Therapy by Drug Therapy, 2020 Ђ“2030 (US$ Million)
10.4.6.2.3 UAE: Breast Cancer Therapeutics Market, by Breast Cancer Type, 2020 Ђ“2030 (US$ Million)
10.4.6.2.4 UAE: Breast Cancer Therapeutics Market, by Distribution Channel, 2020 Ђ“2030 (US$ Million)
10.4.6.3 South Africa
10.4.6.3.1 South Africa Breast Cancer Therapeutics Market Revenue and Forecast to 2030 (US$ Mn)
10.4.6.3.2 South Africa: Breast Cancer Therapeutics Market, by Drug Therapy, 2020 Ђ“2030 (US$ Million)
10.4.6.3.2.1 South Africa: Breast Cancer Therapeutics Market, For Targeted Drug Therapy by Drug Therapy, 2020 Ђ“2030 (US$ Million)
10.4.6.3.2.2 South Africa: Breast Cancer Therapeutics Market, For Hormonal Drug Therapy by Drug Therapy, 2020 Ђ“2030 (US$ Million)
10.4.6.3.3 South Africa: Breast Cancer Therapeutics Market, by Breast Cancer Type, 2020 Ђ“2030 (US$ Million)
10.4.6.3.4 South Africa: Breast Cancer Therapeutics Market, by Distribution Channel, 2020 Ђ“2030 (US$ Million)
10.4.6.4 Rest of Middle East & Africa
10.4.6.4.1 Rest of Middle East & Africa Breast Cancer Therapeutics Market Revenue and Forecast to 2030 (US$ Mn)
10.4.6.4.2 Rest of Middle East & Africa: Breast Cancer Therapeutics Market, by Drug Therapy, 2020 Ђ“2030 (US$ Million)
10.4.6.4.2.1 Rest of Middle East & Africa: Breast Cancer Therapeutics Market, For Targeted Drug Therapy by Drug Therapy, 2020 Ђ“2030 (US$ Million)
10.4.6.4.2.2 Rest of Middle East & Africa: Breast Cancer Therapeutics Market, For Hormonal Drug Therapy by Drug Therapy, 2020 Ђ“2030 (US$ Million)
10.4.6.4.3 Rest of Middle East & Africa: Breast Cancer Therapeutics Market, by Breast Cancer Type, 2020 Ђ“2030 (US$ Million)
10.4.6.4.4 Rest of Middle East & Africa: Breast Cancer Therapeutics Market, by Distribution Channel, 2020 Ђ“2030 (US$ Million)
10.5 South & Central America Breast Cancer Therapeutics Market, Revenue and Forecast to 2030
10.5.1 Overview
10.5.2 South & Central America Breast Cancer Therapeutics Market Revenue and Forecast to 2030 (US$ Mn)
10.5.3 South & Central America: Breast Cancer Therapeutics Market, by Drug Therapy, 2020 Ђ“2030 (US$ Million)
10.5.3.1 South & Central America: Breast Cancer Therapeutics Market, For Targeted Drug Therapy by Drug Therapy, 2020 Ђ“2030 (US$ Million)
10.5.3.2 South & Central America: Breast Cancer Therapeutics Market, For Hormonal Drug Therapy by Drug Therapy, 2020 Ђ“2030 (US$ Million)
10.5.4 South & Central America: Breast Cancer Therapeutics Market, by Breast Cancer Type, 2020 Ђ“2030 (US$ Million)
10.5.5 South & Central America: Breast Cancer Therapeutics Market, by Distribution Channel, 2020 Ђ“2030 (US$ Million)
10.5.6 South & Central America Breast Cancer Therapeutics Market, by Country
10.5.6.1 Brazil
10.5.6.1.1 Brazil Breast Cancer Therapeutics Market Revenue and Forecast to 2030 (US$ Mn)
10.5.6.1.2 Brazil: Breast Cancer Therapeutics Market, by Drug Therapy, 2020 Ђ“2030 (US$ Million)
10.5.6.1.2.1 Brazil: Breast Cancer Therapeutics Market, For Targeted Drug Therapy by Drug Therapy, 2020 Ђ“2030 (US$ Million)
10.5.6.1.2.2 Brazil: Breast Cancer Therapeutics Market, For Hormonal Drug Therapy by Drug Therapy, 2020 Ђ“2030 (US$ Million)
10.5.6.1.3 Brazil: Breast Cancer Therapeutics Market, by Breast Cancer Type, 2020 Ђ“2030 (US$ Million)
10.5.6.1.4 Brazil: Breast Cancer Therapeutics Market, by Distribution Channel, 2020 Ђ“2030 (US$ Million)
10.5.6.2 Argentina
10.5.6.2.1 Argentina Breast Cancer Therapeutics Market Revenue and Forecast to 2030 (US$ Mn)
10.5.6.2.2 Argentina: Breast Cancer Therapeutics Market, by Drug Therapy, 2020 Ђ“2030 (US$ Million)
10.5.6.2.2.1 Argentina: Breast Cancer Therapeutics Market, For Targeted Drug Therapy by Drug Therapy, 2020 Ђ“2030 (US$ Million)
10.5.6.2.2.2 Argentina: Breast Cancer Therapeutics Market, For Hormonal Drug Therapy by Drug Therapy, 2020 Ђ“2030 (US$ Million)
10.5.6.2.3 Argentina: Breast Cancer Therapeutics Market, by Breast Cancer Type, 2020 Ђ“2030 (US$ Million)
10.5.6.2.4 Argentina: Breast Cancer Therapeutics Market, by Distribution Channel, 2020 Ђ“2030 (US$ Million)
10.5.6.3 Rest of South & Central America
10.5.6.3.1 Rest of South & Central America Breast Cancer Therapeutics Market Revenue and Forecast to 2030 (US$ Mn)
10.5.6.3.2 Rest of South & Central America: Breast Cancer Therapeutics Market, by Drug Therapy, 2020 Ђ“2030 (US$ Million)
10.5.6.3.2.1 Rest of South & Central America: Breast Cancer Therapeutics Market, For Targeted Drug Therapy by Drug Therapy, 2020 Ђ“2030 (US$ Million)
10.5.6.3.2.2 Rest of South & Central America: Breast Cancer Therapeutics Market, For Hormonal Drug Therapy by Drug Therapy, 2020 Ђ“2030 (US$ Million)
10.5.6.3.3 Rest of South & Central America: Breast Cancer Therapeutics Market, by Breast Cancer Type, 2020 Ђ“2030 (US$ Million)
10.5.6.3.4 Rest of South & Central America: Breast Cancer Therapeutics Market, by Distribution Channel, 2020 Ђ“2030 (US$ Million)
11. BREAST CANCER THERAPEUTICS MARKET Ђ“INDUSTRY LANDSCAPE
11.1 Overview
11.2 Growth Strategies in Breast Cancer Therapeutics Market
11.3 Organic Growth Strategies
11.3.1 Overview
11.4 Inorganic Growth Strategies
11.4.1 Overview
12. COMPANY PROFILES
12.1 Eli Lilly and Co
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Eisai Co Ltd
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Novartis AG
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 AstraZeneca Plc
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Pfizer Inc
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 Gilead Sciences Inc
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 Merck & Co Inc
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 Genentech Inc.
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
12.9 Teva Pharmaceutical Industries Ltd
12.9.1 Key Facts
12.9.2 Business Description
12.9.3 Products and Services
12.9.4 Financial Overview
12.9.5 SWOT Analysis
12.9.6 Key Developments
12.10 Amgen Inc
12.10.1 Key Facts
12.10.2 Business Description
12.10.3 Products and Services
12.10.4 Financial Overview
12.10.5 SWOT Analysis
12.10.6 Key Developments
13. APPENDIX
13.1 About Us
13.2 Glossary of Terms
1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation
2. EXECUTIVE SUMMARY
2.1 Key Insights
3. RESEARCH METHODOLOGY
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. BREAST CANCER THERAPEUTICS MARKET LANDSCAPE
4.1 Overview
4.2 PEST Analysis
4.2.1 Global PEST Analysis
5. BREAST CANCER THERAPEUTICS MARKET - KEY INDUSTRY DYNAMICS
5.1 Key Market Drivers
5.1.1 Growing Burden of Breast Cancer
5.1.2 Launch of Several Diagnostics and Screening Programs
5.2 Key Market Restraints
5.2.1 High Cost of Diagnosis and Treatment
5.3 Key Market Opportunities
5.3.1 Increased Support from Government and Private Organizations
5.4 Key Future Trends
5.4.1 Increasing Use of Personalized Medicine
5.5 Impact Analysis:
6. BREAST CANCER THERAPEUTICS MARKET - GLOBAL MARKET ANALYSIS
6.1 Breast Cancer Therapeutics Market Revenue (US$ Mn), 2022 2030
7. GLOBAL BREAST CANCER THERAPEUTICS MARKET REVENUE AND FORECAST TO 2030 BY DRUG THERAPY
7.1 Overview
7.2 Breast Cancer Therapeutics Market Revenue Share, by Drug Therapy, 2022 & 2030 (%)
7.3 Targeted Drug Therapy
7.3.1 Overview
7.3.2 Targeted Drug Therapy: Breast Cancer Therapeutics Market Revenue and Forecast to 2030 (US$ Million)
7.3.2.1 Global Breast Cancer Therapeutics Market, by Targeted Drug Therapy, 2020 Ђ“2030 (US$ Million)
7.4 Hormonal Drug Therapy
7.4.1 Overview
7.4.2 Hormonal Drug Therapy: Breast Cancer Therapeutics Market Revenue and Forecast to 2030 (US$ Million)
7.5 Chemotherapy
7.5.1 Overview
7.5.2 Chemotherapy: Breast Cancer Therapeutics Market Revenue and Forecast to 2030 (US$ Million)
7.6 Immunotherapy/ Biological Therapy
7.6.1 Overview
7.6.2 Immunotherapy/ Biological Therapy: Breast Cancer Therapeutics Market Revenue and Forecast to 2030 (US$ Million)
8. GLOBAL BREAST CANCER THERAPEUTICS MARKET REVENUE AND FORECAST TO 2030 BY BREAST CANCER TYPE
8.1 Overview
8.2 Breast Cancer Therapeutics Market Revenue Share, by Breast Cancer Type, 2022 & 2030 (%)
8.3 Hormone Receptor
8.3.1 Overview
8.3.2 Hormone Receptor: Breast Cancer Therapeutics Market Revenue and Forecast to 2030 (US$ Million)
8.4 HER2+ (human epidermal growth factor receptor 2)
8.4.1 Overview
8.4.2 HER2+: Breast Cancer Therapeutics Market Revenue and Forecast to 2030 (US$ Million)
8.5 Triple-Negative Breast Cancer
8.5.1 Overview
8.5.2 Triple-Negative Breast Cancer: Breast Cancer Therapeutics Market Revenue and Forecast to 2030 (US$ Million)
9. GLOBAL BREAST CANCER THERAPEUTICS MARKET REVENUE AND FORECAST TO 2030 BY DISTRIBUTION CHANNEL
9.1 Overview
9.2 Breast Cancer Therapeutics Market Revenue Share, by Distribution Channel, 2022 & 2030 (%)
9.3 Hospital Pharmacies
9.3.1 Overview
9.3.2 Hospital Pharmacies: Breast Cancer Therapeutics Market Revenue and Forecast to 2030 (US$ Million)
9.4 Drug Store and Retail Pharmacies
9.4.1 Overview
9.4.2 Drug Store and Retail Pharmacies: Breast Cancer Therapeutics Market Revenue and Forecast to 2030 (US$ Million)
9.5 Online Pharmacies
9.5.1 Overview
9.5.2 Online Pharmacies: Breast Cancer Therapeutics Market Revenue and Forecast to 2030 (US$ Million)
10. BREAST CANCER THERAPEUTICS MARKET - GEOGRAPHICAL ANALYSIS
10.1 North America Breast Cancer Therapeutics Market, Revenue and Forecast To 2030
10.1.1 Overview
10.1.2 North America Breast Cancer Therapeutics Market Revenue and Forecast to 2030 (US$ Mn)
10.1.3 North America: Breast Cancer Therapeutics Market, by Drug Therapy, 2020 Ђ“2030 (US$ Million)
10.1.3.1 North America: Breast Cancer Therapeutics Market, For Targeted Drug Therapy by Drug Therapy, 2020 Ђ“2030 (US$ Million)
10.1.3.2 North America: Breast Cancer Therapeutics Market, For Hormonal Drug Therapy by Drug Therapy, 2020 Ђ“2030 (US$ Million)
10.1.4 North America: Breast Cancer Therapeutics Market, by Breast Cancer Type, 2020 Ђ“2030 (US$ Million)
10.1.5 North America: Breast Cancer Therapeutics Market, by Distribution Channel, 2020 Ђ“2030 (US$ Million)
10.1.6 North America Breast Cancer Therapeutics Market, by Country
10.1.6.1 US
10.1.6.1.1 US Breast Cancer Therapeutics Market Revenue and Forecast to 2030 (US$ Mn)
10.1.6.1.2 US: Breast Cancer Therapeutics Market, by Drug Therapy, 2020 Ђ“2030 (US$ Million)
10.1.6.1.2.1 US: Breast Cancer Therapeutics Market, For Targeted Drug Therapy by Drug Therapy, 2020 Ђ“2030 (US$ Million)
10.1.6.1.2.2 US: Breast Cancer Therapeutics Market, For Hormonal Drug Therapy by Drug Therapy, 2020 Ђ“2030 (US$ Million)
10.1.6.1.3 US: Breast Cancer Therapeutics Market, by Breast Cancer Type, 2020 Ђ“2030 (US$ Million)
10.1.6.1.4 US: Breast Cancer Therapeutics Market, by Distribution Channel, 2020 Ђ“2030 (US$ Million)
10.1.6.2 Canada
10.1.6.2.1 Canada Breast Cancer Therapeutics Market Revenue and Forecast to 2030 (US$ Mn)
10.1.6.2.2 Canada: Breast Cancer Therapeutics Market, by Drug Therapy, 2020 Ђ“2030 (US$ Million)
10.1.6.2.2.1 Canada: Breast Cancer Therapeutics Market, For Targeted Drug Therapy by Drug Therapy, 2020 Ђ“2030 (US$ Million)
10.1.6.2.2.2 Canada: Breast Cancer Therapeutics Market, For Hormonal Drug Therapy by Drug Therapy, 2020 Ђ“2030 (US$ Million)
10.1.6.2.3 Canada: Breast Cancer Therapeutics Market, by Breast Cancer Type, 2020 Ђ“2030 (US$ Million)
10.1.6.2.4 Canada: Breast Cancer Therapeutics Market, by Distribution Channel, 2020 Ђ“2030 (US$ Million)
10.1.6.3 Mexico
10.1.6.3.1 Mexico Breast Cancer Therapeutics Market Revenue and Forecast to 2030 (US$ Mn)
10.1.6.3.2 Mexico: Breast Cancer Therapeutics Market, by Drug Therapy, 2020 Ђ“2030 (US$ Million)
10.1.6.3.2.1 Mexico: Breast Cancer Therapeutics Market, For Targeted Drug Therapy by Drug Therapy, 2020 Ђ“2030 (US$ Million)
10.1.6.3.2.2 Mexico: Breast Cancer Therapeutics Market, For Hormonal Drug Therapy by Drug Therapy, 2020 Ђ“2030 (US$ Million)
10.1.6.3.3 Mexico: Breast Cancer Therapeutics Market, by Breast Cancer Type, 2020 Ђ“2030 (US$ Million)
10.1.6.3.4 Mexico: Breast Cancer Therapeutics Market, by Distribution Channel, 2020 Ђ“2030 (US$ Million)
10.2 Europe Breast Cancer Therapeutics Market, Revenue and Forecast to 2030
10.2.1 Overview
10.2.2 Europe Breast Cancer Therapeutics Market Revenue and Forecast to 2030 (US$ Mn)
10.2.3 Europe: Breast Cancer Therapeutics Market, by Drug Therapy, 2020 Ђ“2030 (US$ Million)
10.2.3.1 Europe: Breast Cancer Therapeutics Market, For Targeted Drug Therapy by Drug Therapy, 2020 Ђ“2030 (US$ Million)
10.2.3.2 Europe: Breast Cancer Therapeutics Market, For Hormonal Drug Therapy by Drug Therapy, 2020 Ђ“2030 (US$ Million)
10.2.4 Europe: Breast Cancer Therapeutics Market, by Breast Cancer Type, 2020 Ђ“2030 (US$ Million)
10.2.5 Europe: Breast Cancer Therapeutics Market, by Distribution Channel, 2020 Ђ“2030 (US$ Million)
10.2.6 Europe Breast Cancer Therapeutics Market, by Country
10.2.6.1 UK
10.2.6.1.1 UK Breast Cancer Therapeutics Market Revenue and Forecast to 2030 (US$ Mn)
10.2.6.1.2 UK: Breast Cancer Therapeutics Market, by Drug Therapy, 2020 Ђ“2030 (US$ Million)
10.2.6.1.2.1 UK: Breast Cancer Therapeutics Market, For Targeted Drug Therapy by Drug Therapy, 2020 Ђ“2030 (US$ Million)
10.2.6.1.2.2 UK: Breast Cancer Therapeutics Market, For Hormonal Drug Therapy by Drug Therapy, 2020 Ђ“2030 (US$ Million)
10.2.6.1.3 UK: Breast Cancer Therapeutics Market, by Breast Cancer Type, 2020 Ђ“2030 (US$ Million)
10.2.6.1.4 UK: Breast Cancer Therapeutics Market, by Distribution Channel, 2020 Ђ“2030 (US$ Million)
10.2.6.2 Germany
10.2.6.2.1 Germany Breast Cancer Therapeutics Market Revenue and Forecast to 2030 (US$ Mn)
10.2.6.2.2 Germany: Breast Cancer Therapeutics Market, by Drug Therapy, 2020 Ђ“2030 (US$ Million)
10.2.6.2.2.1 Germany: Breast Cancer Therapeutics Market, For Targeted Drug Therapy by Drug Therapy, 2020 Ђ“2030 (US$ Million)
10.2.6.2.2.2 Germany: Breast Cancer Therapeutics Market, For Hormonal Drug Therapy by Drug Therapy, 2020 Ђ“2030 (US$ Million)
10.2.6.2.3 Germany: Breast Cancer Therapeutics Market, by Breast Cancer Type, 2020 Ђ“2030 (US$ Million)
10.2.6.2.4 Germany: Breast Cancer Therapeutics Market, by Distribution Channel, 2020 Ђ“2030 (US$ Million)
10.2.6.3 France
10.2.6.3.1 France Breast Cancer Therapeutics Market Revenue and Forecast to 2030 (US$ Mn)
10.2.6.3.2 France: Breast Cancer Therapeutics Market, by Drug Therapy, 2020 Ђ“2030 (US$ Million)
10.2.6.3.2.1 France: Breast Cancer Therapeutics Market, For Targeted Drug Therapy by Drug Therapy, 2020 Ђ“2030 (US$ Million)
10.2.6.3.2.2 France: Breast Cancer Therapeutics Market, For Hormonal Drug Therapy by Drug Therapy, 2020 Ђ“2030 (US$ Million)
10.2.6.3.3 France: Breast Cancer Therapeutics Market, by Breast Cancer Type, 2020 Ђ“2030 (US$ Million)
10.2.6.3.4 France: Breast Cancer Therapeutics Market, by Distribution Channel, 2020 Ђ“2030 (US$ Million)
10.2.6.4 Italy
10.2.6.4.1 Italy Breast Cancer Therapeutics Market Revenue and Forecast to 2030 (US$ Mn)
10.2.6.4.2 Italy: Breast Cancer Therapeutics Market, by Drug Therapy, 2020 Ђ“2030 (US$ Million)
10.2.6.4.2.1 Italy: Breast Cancer Therapeutics Market, For Targeted Drug Therapy by Drug Therapy, 2020 Ђ“2030 (US$ Million)
10.2.6.4.2.2 Italy: Breast Cancer Therapeutics Market, For Hormonal Drug Therapy by Drug Therapy, 2020 Ђ“2030 (US$ Million)
10.2.6.4.3 Italy: Breast Cancer Therapeutics Market, by Breast Cancer Type, 2020 Ђ“2030 (US$ Million)
10.2.6.4.4 Italy: Breast Cancer Therapeutics Market, by Distribution Channel, 2020 Ђ“2030 (US$ Million)
10.2.6.5 Spain
10.2.6.5.1 Spain Breast Cancer Therapeutics Market Revenue and Forecast to 2030 (US$ Mn)
10.2.6.5.2 Spain: Breast Cancer Therapeutics Market, by Drug Therapy, 2020 Ђ“2030 (US$ Million)
10.2.6.5.2.1 Spain: Breast Cancer Therapeutics Market, For Targeted Drug Therapy by Drug Therapy, 2020 Ђ“2030 (US$ Million)
10.2.6.5.2.2 Spain: Breast Cancer Therapeutics Market, For Hormonal Drug Therapy by Drug Therapy, 2020 Ђ“2030 (US$ Million)
10.2.6.5.3 Spain: Breast Cancer Therapeutics Market, by Breast Cancer Type, 2020 Ђ“2030 (US$ Million)
10.2.6.5.4 Spain: Breast Cancer Therapeutics Market, by Distribution Channel, 2020 Ђ“2030 (US$ Million)
10.2.6.6 Rest of Europe
10.2.6.6.1 Rest of Europe Breast Cancer Therapeutics Market Revenue and Forecast to 2030 (US$ Mn)
10.2.6.6.2 Rest of Europe: Breast Cancer Therapeutics Market, by Drug Therapy, 2020 Ђ“2030 (US$ Million)
10.2.6.6.2.1 Rest of Europe: Breast Cancer Therapeutics Market, For Targeted Drug Therapy by Drug Therapy, 2020 Ђ“2030 (US$ Million)
10.2.6.6.2.2 Rest of Europe: Breast Cancer Therapeutics Market, For Hormonal Drug Therapy by Drug Therapy, 2020 Ђ“2030 (US$ Million)
10.2.6.6.3 Rest of Europe: Breast Cancer Therapeutics Market, by Breast Cancer Type, 2020 Ђ“2030 (US$ Million)
10.2.6.6.4 Rest of Europe: Breast Cancer Therapeutics Market, by Distribution Channel, 2020 Ђ“2030 (US$ Million)
10.3 Asia Pacific Breast Cancer Therapeutics Market, Revenue and Forecast to 2030
10.3.1 Overview
10.3.2 Asia Pacific Breast Cancer Therapeutics Market Revenue and Forecast to 2030 (US$ Mn)
10.3.3 Asia Pacific: Breast Cancer Therapeutics Market, by Drug Therapy, 2020 Ђ“2030 (US$ Million)
10.3.3.1 Asia Pacific: Breast Cancer Therapeutics Market, For Targeted Drug Therapy by Drug Therapy, 2020 Ђ“2030 (US$ Million)
10.3.3.2 Asia Pacific: Breast Cancer Therapeutics Market, For Hormonal Drug Therapy by Drug Therapy, 2020 Ђ“2030 (US$ Million)
10.3.4 Asia Pacific: Breast Cancer Therapeutics Market, by Breast Cancer Type, 2020 Ђ“2030 (US$ Million)
10.3.5 Asia Pacific: Breast Cancer Therapeutics Market, by Distribution Channel, 2020 Ђ“2030 (US$ Million)
10.3.6 Asia Pacific Breast Cancer Therapeutics Market, by Country
10.3.6.1 China
10.3.6.1.1 China Breast Cancer Therapeutics Market Revenue and Forecast to 2030 (US$ Mn)
10.3.6.1.2 China: Breast Cancer Therapeutics Market, by Drug Therapy, 2020 Ђ“2030 (US$ Million)
10.3.6.1.2.1 China: Breast Cancer Therapeutics Market, For Targeted Drug Therapy by Drug Therapy, 2020 Ђ“2030 (US$ Million)
10.3.6.1.2.2 China: Breast Cancer Therapeutics Market, For Hormonal Drug Therapy by Drug Therapy, 2020 Ђ“2030 (US$ Million)
10.3.6.1.3 China: Breast Cancer Therapeutics Market, by Breast Cancer Type, 2020 Ђ“2030 (US$ Million)
10.3.6.1.4 China: Breast Cancer Therapeutics Market, by Distribution Channel, 2020 Ђ“2030 (US$ Million)
10.3.6.2 Japan
10.3.6.2.1 Japan Breast Cancer Therapeutics Market Revenue and Forecast to 2030 (US$ Mn)
10.3.6.2.2 Japan: Breast Cancer Therapeutics Market, by Drug Therapy, 2020 Ђ“2030 (US$ Million)
10.3.6.2.2.1 Japan: Breast Cancer Therapeutics Market, For Targeted Drug Therapy by Drug Therapy, 2020 Ђ“2030 (US$ Million)
10.3.6.2.2.2 Japan: Breast Cancer Therapeutics Market, For Hormonal Drug Therapy by Drug Therapy, 2020 Ђ“2030 (US$ Million)
10.3.6.2.3 Japan: Breast Cancer Therapeutics Market, by Breast Cancer Type, 2020 Ђ“2030 (US$ Million)
10.3.6.2.4 Japan: Breast Cancer Therapeutics Market, by Distribution Channel, 2020 Ђ“2030 (US$ Million)
10.3.6.3 India
10.3.6.3.1 India Breast Cancer Therapeutics Market Revenue and Forecast to 2030 (US$ Mn)
10.3.6.3.2 India: Breast Cancer Therapeutics Market, by Drug Therapy, 2020 Ђ“2030 (US$ Million)
10.3.6.3.2.1 India: Breast Cancer Therapeutics Market, For Targeted Drug Therapy by Drug Therapy, 2020 Ђ“2030 (US$ Million)
10.3.6.3.2.2 India: Breast Cancer Therapeutics Market, For Hormonal Drug Therapy by Drug Therapy, 2020 Ђ“2030 (US$ Million)
10.3.6.3.3 India: Breast Cancer Therapeutics Market, by Breast Cancer Type, 2020 Ђ“2030 (US$ Million)
10.3.6.3.4 India: Breast Cancer Therapeutics Market, by Distribution Channel, 2020 Ђ“2030 (US$ Million)
10.3.6.4 Australia
10.3.6.4.1 Australia Breast Cancer Therapeutics Market Revenue and Forecast to 2030 (US$ Mn)
10.3.6.4.2 Australia: Breast Cancer Therapeutics Market, by Drug Therapy, 2020 Ђ“2030 (US$ Million)
10.3.6.4.2.1 Australia: Breast Cancer Therapeutics Market, For Targeted Drug Therapy by Drug Therapy, 2020 Ђ“2030 (US$ Million)
10.3.6.4.2.2 Australia: Breast Cancer Therapeutics Market, For Hormonal Drug Therapy by Drug Therapy, 2020 Ђ“2030 (US$ Million)
10.3.6.4.3 Australia: Breast Cancer Therapeutics Market, by Breast Cancer Type, 2020 Ђ“2030 (US$ Million)
10.3.6.4.4 Australia: Breast Cancer Therapeutics Market, by Distribution Channel, 2020 Ђ“2030 (US$ Million)
10.3.6.5 South Korea
10.3.6.5.1 South Korea Breast Cancer Therapeutics Market Revenue and Forecast to 2030 (US$ Mn)
10.3.6.5.2 South Korea: Breast Cancer Therapeutics Market, by Drug Therapy, 2020 Ђ“2030 (US$ Million)
10.3.6.5.2.1 South Korea: Breast Cancer Therapeutics Market, For Targeted Drug Therapy by Drug Therapy, 2020 Ђ“2030 (US$ Million)
10.3.6.5.2.2 South Korea: Breast Cancer Therapeutics Market, For Hormonal Drug Therapy by Drug Therapy, 2020 Ђ“2030 (US$ Million)
10.3.6.5.3 South Korea: Breast Cancer Therapeutics Market, by Breast Cancer Type, 2020 Ђ“2030 (US$ Million)
10.3.6.5.4 South Korea: Breast Cancer Therapeutics Market, by Distribution Channel, 2020 Ђ“2030 (US$ Million)
10.3.6.6 Rest of Asia Pacific
10.3.6.6.1 Rest of Asia Pacific Breast Cancer Therapeutics Market Revenue and Forecast to 2030 (US$ Mn)
10.3.6.6.2 Rest of Asia Pacific: Breast Cancer Therapeutics Market, by Drug Therapy, 2020 Ђ“2030 (US$ Million)
10.3.6.6.2.1 Rest of Asia Pacific: Breast Cancer Therapeutics Market, For Targeted Drug Therapy by Drug Therapy, 2020 Ђ“2030 (US$ Million)
10.3.6.6.2.2 Rest of Asia Pacific: Breast Cancer Therapeutics Market, For Hormonal Drug Therapy by Drug Therapy, 2020 Ђ“2030 (US$ Million)
10.3.6.6.3 Rest of Asia Pacific: Breast Cancer Therapeutics Market, by Breast Cancer Type, 2020 Ђ“2030 (US$ Million)
10.3.6.6.4 Rest of Asia Pacific: Breast Cancer Therapeutics Market, by Distribution Channel, 2020 Ђ“2030 (US$ Million)
10.4 Middle East & Africa Breast Cancer Therapeutics Market, Revenue and Forecast to 2030
10.4.1 Overview
10.4.2 Middle East & Africa Breast Cancer Therapeutics Market Revenue and Forecast to 2030 (US$ Mn)
10.4.3 Middle East & Africa: Breast Cancer Therapeutics Market, by Drug Therapy, 2020 Ђ“2030 (US$ Million)
10.4.3.1 Middle East & Africa: Breast Cancer Therapeutics Market, For Targeted Drug Therapy by Drug Therapy, 2020 Ђ“2030 (US$ Million)
10.4.3.2 Middle East & Africa: Breast Cancer Therapeutics Market, For Hormonal Drug Therapy by Drug Therapy, 2020 Ђ“2030 (US$ Million)
10.4.4 Middle East & Africa: Breast Cancer Therapeutics Market, by Breast Cancer Type, 2020 Ђ“2030 (US$ Million)
10.4.5 Middle East & Africa: Breast Cancer Therapeutics Market, by Distribution Channel, 2020 Ђ“2030 (US$ Million)
10.4.6 Middle East & Africa Breast Cancer Therapeutics Market, by Country
10.4.6.1 Saudi Arabia
10.4.6.1.1 Saudi Arabia Breast Cancer Therapeutics Market Revenue and Forecast to 2030 (US$ Mn)
10.4.6.1.2 Saudi Arabia: Breast Cancer Therapeutics Market, by Drug Therapy, 2020 Ђ“2030 (US$ Million)
10.4.6.1.2.1 Saudi Arabia: Breast Cancer Therapeutics Market, For Targeted Drug Therapy by Drug Therapy, 2020 Ђ“2030 (US$ Million)
10.4.6.1.2.2 Saudi Arabia: Breast Cancer Therapeutics Market, For Hormonal Drug Therapy by Drug Therapy, 2020 Ђ“2030 (US$ Million)
10.4.6.1.3 Saudi Arabia: Breast Cancer Therapeutics Market, by Breast Cancer Type, 2020 Ђ“2030 (US$ Million)
10.4.6.1.4 Saudi Arabia: Breast Cancer Therapeutics Market, by Distribution Channel, 2020 Ђ“2030 (US$ Million)
10.4.6.2 UAE
10.4.6.2.1 UAE Breast Cancer Therapeutics Market Revenue and Forecast to 2030 (US$ Mn)
10.4.6.2.2 UAE: Breast Cancer Therapeutics Market, by Drug Therapy, 2020 Ђ“2030 (US$ Million)
10.4.6.2.2.1 UAE: Breast Cancer Therapeutics Market, For Targeted Drug Therapy by Drug Therapy, 2020 Ђ“2030 (US$ Million)
10.4.6.2.2.2 UAE: Breast Cancer Therapeutics Market, For Hormonal Drug Therapy by Drug Therapy, 2020 Ђ“2030 (US$ Million)
10.4.6.2.3 UAE: Breast Cancer Therapeutics Market, by Breast Cancer Type, 2020 Ђ“2030 (US$ Million)
10.4.6.2.4 UAE: Breast Cancer Therapeutics Market, by Distribution Channel, 2020 Ђ“2030 (US$ Million)
10.4.6.3 South Africa
10.4.6.3.1 South Africa Breast Cancer Therapeutics Market Revenue and Forecast to 2030 (US$ Mn)
10.4.6.3.2 South Africa: Breast Cancer Therapeutics Market, by Drug Therapy, 2020 Ђ“2030 (US$ Million)
10.4.6.3.2.1 South Africa: Breast Cancer Therapeutics Market, For Targeted Drug Therapy by Drug Therapy, 2020 Ђ“2030 (US$ Million)
10.4.6.3.2.2 South Africa: Breast Cancer Therapeutics Market, For Hormonal Drug Therapy by Drug Therapy, 2020 Ђ“2030 (US$ Million)
10.4.6.3.3 South Africa: Breast Cancer Therapeutics Market, by Breast Cancer Type, 2020 Ђ“2030 (US$ Million)
10.4.6.3.4 South Africa: Breast Cancer Therapeutics Market, by Distribution Channel, 2020 Ђ“2030 (US$ Million)
10.4.6.4 Rest of Middle East & Africa
10.4.6.4.1 Rest of Middle East & Africa Breast Cancer Therapeutics Market Revenue and Forecast to 2030 (US$ Mn)
10.4.6.4.2 Rest of Middle East & Africa: Breast Cancer Therapeutics Market, by Drug Therapy, 2020 Ђ“2030 (US$ Million)
10.4.6.4.2.1 Rest of Middle East & Africa: Breast Cancer Therapeutics Market, For Targeted Drug Therapy by Drug Therapy, 2020 Ђ“2030 (US$ Million)
10.4.6.4.2.2 Rest of Middle East & Africa: Breast Cancer Therapeutics Market, For Hormonal Drug Therapy by Drug Therapy, 2020 Ђ“2030 (US$ Million)
10.4.6.4.3 Rest of Middle East & Africa: Breast Cancer Therapeutics Market, by Breast Cancer Type, 2020 Ђ“2030 (US$ Million)
10.4.6.4.4 Rest of Middle East & Africa: Breast Cancer Therapeutics Market, by Distribution Channel, 2020 Ђ“2030 (US$ Million)
10.5 South & Central America Breast Cancer Therapeutics Market, Revenue and Forecast to 2030
10.5.1 Overview
10.5.2 South & Central America Breast Cancer Therapeutics Market Revenue and Forecast to 2030 (US$ Mn)
10.5.3 South & Central America: Breast Cancer Therapeutics Market, by Drug Therapy, 2020 Ђ“2030 (US$ Million)
10.5.3.1 South & Central America: Breast Cancer Therapeutics Market, For Targeted Drug Therapy by Drug Therapy, 2020 Ђ“2030 (US$ Million)
10.5.3.2 South & Central America: Breast Cancer Therapeutics Market, For Hormonal Drug Therapy by Drug Therapy, 2020 Ђ“2030 (US$ Million)
10.5.4 South & Central America: Breast Cancer Therapeutics Market, by Breast Cancer Type, 2020 Ђ“2030 (US$ Million)
10.5.5 South & Central America: Breast Cancer Therapeutics Market, by Distribution Channel, 2020 Ђ“2030 (US$ Million)
10.5.6 South & Central America Breast Cancer Therapeutics Market, by Country
10.5.6.1 Brazil
10.5.6.1.1 Brazil Breast Cancer Therapeutics Market Revenue and Forecast to 2030 (US$ Mn)
10.5.6.1.2 Brazil: Breast Cancer Therapeutics Market, by Drug Therapy, 2020 Ђ“2030 (US$ Million)
10.5.6.1.2.1 Brazil: Breast Cancer Therapeutics Market, For Targeted Drug Therapy by Drug Therapy, 2020 Ђ“2030 (US$ Million)
10.5.6.1.2.2 Brazil: Breast Cancer Therapeutics Market, For Hormonal Drug Therapy by Drug Therapy, 2020 Ђ“2030 (US$ Million)
10.5.6.1.3 Brazil: Breast Cancer Therapeutics Market, by Breast Cancer Type, 2020 Ђ“2030 (US$ Million)
10.5.6.1.4 Brazil: Breast Cancer Therapeutics Market, by Distribution Channel, 2020 Ђ“2030 (US$ Million)
10.5.6.2 Argentina
10.5.6.2.1 Argentina Breast Cancer Therapeutics Market Revenue and Forecast to 2030 (US$ Mn)
10.5.6.2.2 Argentina: Breast Cancer Therapeutics Market, by Drug Therapy, 2020 Ђ“2030 (US$ Million)
10.5.6.2.2.1 Argentina: Breast Cancer Therapeutics Market, For Targeted Drug Therapy by Drug Therapy, 2020 Ђ“2030 (US$ Million)
10.5.6.2.2.2 Argentina: Breast Cancer Therapeutics Market, For Hormonal Drug Therapy by Drug Therapy, 2020 Ђ“2030 (US$ Million)
10.5.6.2.3 Argentina: Breast Cancer Therapeutics Market, by Breast Cancer Type, 2020 Ђ“2030 (US$ Million)
10.5.6.2.4 Argentina: Breast Cancer Therapeutics Market, by Distribution Channel, 2020 Ђ“2030 (US$ Million)
10.5.6.3 Rest of South & Central America
10.5.6.3.1 Rest of South & Central America Breast Cancer Therapeutics Market Revenue and Forecast to 2030 (US$ Mn)
10.5.6.3.2 Rest of South & Central America: Breast Cancer Therapeutics Market, by Drug Therapy, 2020 Ђ“2030 (US$ Million)
10.5.6.3.2.1 Rest of South & Central America: Breast Cancer Therapeutics Market, For Targeted Drug Therapy by Drug Therapy, 2020 Ђ“2030 (US$ Million)
10.5.6.3.2.2 Rest of South & Central America: Breast Cancer Therapeutics Market, For Hormonal Drug Therapy by Drug Therapy, 2020 Ђ“2030 (US$ Million)
10.5.6.3.3 Rest of South & Central America: Breast Cancer Therapeutics Market, by Breast Cancer Type, 2020 Ђ“2030 (US$ Million)
10.5.6.3.4 Rest of South & Central America: Breast Cancer Therapeutics Market, by Distribution Channel, 2020 Ђ“2030 (US$ Million)
11. BREAST CANCER THERAPEUTICS MARKET Ђ“INDUSTRY LANDSCAPE
11.1 Overview
11.2 Growth Strategies in Breast Cancer Therapeutics Market
11.3 Organic Growth Strategies
11.3.1 Overview
11.4 Inorganic Growth Strategies
11.4.1 Overview
12. COMPANY PROFILES
12.1 Eli Lilly and Co
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Eisai Co Ltd
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Novartis AG
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 AstraZeneca Plc
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Pfizer Inc
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 Gilead Sciences Inc
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 Merck & Co Inc
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 Genentech Inc.
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
12.9 Teva Pharmaceutical Industries Ltd
12.9.1 Key Facts
12.9.2 Business Description
12.9.3 Products and Services
12.9.4 Financial Overview
12.9.5 SWOT Analysis
12.9.6 Key Developments
12.10 Amgen Inc
12.10.1 Key Facts
12.10.2 Business Description
12.10.3 Products and Services
12.10.4 Financial Overview
12.10.5 SWOT Analysis
12.10.6 Key Developments
13. APPENDIX
13.1 About Us
13.2 Glossary of Terms
